Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Iloprost for the treatment of Acute Respiratory Distress Syndrome (ARDS) (ThIlo-Trial)
2016-003168-37Phase 2Completed
- Sponsor
- University of Tübingen
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of iloprost in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by University of Tübingen. Primary endpoint: Improvement of oxygenation. Started Nov 2018; status: completed.
02
Drugs
iloprost
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2016-003168-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003168-37.